Ulcerative Colitis

Phase III Trial of Afimkibart Shows Promise for Ulcerative Colitis

A Phase III trial is underway to assess the efficacy and safety of Afimkibart in patients with moderately to severely active ulcerative colitis.

Genentech's Vixarelimab Shows Promise in Moderate to Severe Ulcerative Colitis

A study is underway to evaluate the pharmacodynamic effects of vixarelimab in patients with moderate to severe active ulcerative colitis.

Study on Zonulin and LBP as Biomarkers in UC and Liver Disease

The study aims to explore the relationship between zonulin, LBP biomarkers, and liver conditions in UC patients.

AbbVie initiates pediatric study of Risankizumab for Ulcerative Colitis

A new study is underway to evaluate the safety and efficacy of Risankizumab in pediatric patients with moderate to severe Ulcerative Colitis.

Merck's Tulisokibart Achieves Key Endpoints in Phase 3 UC Study

Tulisokibart met its primary endpoint of clinical remission at 12 weeks in Phase 3 trial for ulcerative colitis.

Eli Lilly's LY4268989 Study with Mirikizumab in Ulcerative Colitis Underway

A clinical trial is evaluating the safety and effectiveness of LY4268989 co-administered with mirikizumab in adults with moderately to severely active ulcerative colitis.

Boomerang Medical initiates pivotal trial for device in ulcerative colitis

Boomerang Medical is conducting a pivotal trial to evaluate a device aimed at reducing bowel urgency in ulcerative colitis patients.

Phase III Trial of Hemay005 in Chinese Patients with Ulcerative Colitis Initiated

A phase III trial has been initiated to evaluate Hemay005 for the treatment of moderately to severely active ulcerative colitis in Chinese patients.

Pfizer's Phase 3 Study of Tofacitinib in Pediatric Ulcerative Colitis Underway

Phase 3 Study of Duvakitug for Moderately to Severely Active Ulcerative Colitis Initiated

A Phase 3 maintenance study is underway to evaluate duvakitug's efficacy and safety in patients with moderately to severely active Ulcerative Colitis.